Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
This study has been completed.
Study NCT00535145   Information provided by Ortho-McNeil Janssen Scientific Affairs, LLC
First Received: September 24, 2007   Last Updated: June 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Psychotic Disorders
Additional conditions recognized in this trial
Disease
Liver Diseases
More general conditions related to this trial
Digestive System Diseases
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Additional drug interventions recognized in this trial
9-hydroxy-risperidone
Antipsychotic Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Ortho-McNeil Janssen Scientific Affairs, LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services